Krisgo, I am looking forward to this coming week too.
My optimism. I believe the very segmented and compartmentalized cancer therapy market will be transformed into a single large green field opportunity because DCVax technology platform is a broad-spectrum cancer vaccine. I want to emphasize vaccine (efficacy, non-toxic, and immune memory) as opposed to drug (single antigen target, high risk for toxicity, and not-a-cure).
We Longs all need to stick together, remain disciplined, and trust our due diligence. The market manipulators are still trying to gaslight us into selling, trading, and or lend out our shares. The true potential though is to just hold. Short term has a major asymmetric upside opportunity, and long-term has us invested in a unicorn company. Best to all Longs.
Bullish